Contact Information
General Information
Introduction: When medical expertise meets precision technology
In the rapidly evolving world of oncology, accurate diagnosis alone is not enough; a treatment plan that combines cutting-edge technology with deep clinical expertise is required. Here the name stands out Dr. Haitham Muhammad Al-Sarairah As one of the leading radiation oncology consultants in Jordan and the region.
With a career spanning more than two decades With an academic background combining prestigious medical schools in Greece and practical experience in Jordan, Dr. Haitham presents a model of a physician who combines administrative leadership (as former head of the Therapeutic Radiology Department in the Royal Medical Services) with rigorous scientific research..
1. Academic Background: A Journey from Jordan to Greece
A solid foundation is the secret to medical success. Dr. Haitham's journey began in his hometown in Zarqa, Jordan To launch towards global recognition through prestigious academic institutions:
Bachelor's Degree and General Medicine
Dr. Haitham graduated from Aristotle University of Thessaloniki In Greece in 2003. Studying in Greece, considered the cradle of Western medicine, gave him a distinct European medical perspective, in addition to his fluency in Greek alongside English and Arabic..
Double Board Certification
What distinguishes Dr. Haitham is that he obtained specialist certificates from two different countries, reflecting rigorous training standards:
-
Greek Board of Radiation Oncology (2014): He obtained it after years of residency and training in hospitals of the Greek Ministry of Health and the METAXA Cancer Hospital in Athens..
-
Jordanian Board in Radiation Oncology (2017): This makes him licensed and accredited as a consultant in Jordan with the highest qualifications..
Specialty: Thoracic Oncology
Dr. Haitham did not limit himself to general oncology medicine, but also obtained a postgraduate degree in breast tumors From the National and Kapodistrian University of Athens in 2016 with a grade of “very good”.”. This precise specialization makes him an expert in dealing with cancers of the lung, esophagus, and thoracic region, which require extreme precision in radiation therapy to avoid vital organs such as the heart.
2. Professional and leadership experience: from the Royal Service to the private sector
Dr. Haitham has a distinguished record in military and civilian medical institutions, which has given him experience in dealing with thousands of diverse cases.
Head of the Therapeutic Radiology Department at the Royal Medical Services
The Royal Medical Services is a major medical institution in Jordan. Dr. Haitham rose through the ranks there until he reached the top.
-
Head of the Radiation Oncology Department (January 2019 – October 2023): Managing an entire department in an institution the size of the Royal Services means overseeing treatment protocols, ensuring quality, and training resident physicians..
-
Senior Specialist and Consultant: He worked for years as a specialist and consultant treating referred and complex cases..
Retirement and move to the private sector
On February 1, 2025, Dr. Haitham retired from the Royal Medical Services to dedicate himself to working in Private sector. This transition represents an opportunity for patients to receive direct and flexible care from a doctor who has the experience of large institutions but with the touch of a private clinic.
3. Advanced treatment techniques: How does Dr. Haitham treat cancer?
One of the most important parts of Dr. Haitham's biography is his mastery of modern techniques in radiotherapy.. For the patient, these terms mean “fewer side effects and higher recovery outcomes.” Let’s explain in detail:
1. Intensity-Modulated Radiation Therapy (IMRT)
This technique allows Dr. Haitham to shape the radiation beam to precisely match the tumor's three-dimensional form. This means striking cancer cells with force while protecting the surrounding healthy tissue.
2. Modified Volumetric Arc Therapy (VMAT)
A very advanced technology allows the treatment device to rotate around the patient to deliver the radiation dose in a very short time and with high accuracy, which increases patient comfort and reduces session time.
3. Radiosurgery (SRS & SBRT)
-
SRS (Stereotactic Radiosurgery): It is used to treat small brain tumors with millimeter precision, and is often an alternative to traditional surgery..
-
SBRT (Stereotactic Body Radiotherapy): It is used for body tumors (such as lung and liver) in high, concentrated doses in a very small number of sessions.
4. Radiological Planning and Medical Physics
Dr. Haitham is proficient in using complex planning software such as (Eclipse, Monaco, RayStation).. This means that he not only writes the prescription, but also technically supervises how the dose is distributed within the patient's body to ensure complete safety.
4. Research and scientific impact: Physician and thinker
Dr. Haitham did not isolate himself from the global scientific community. His publications list indicates research interests that directly benefit the patient..
Leadership during the Coronavirus (COVID-19) pandemic
Dr. Haitham participated as a member of international committees that included experts from 25 countries to develop protocols for treating cancer patients during the pandemic.
-
Publishing research papers on “Supporting patients in the age of pseudo-electronic medicine”.
-
Contribute to the development Vaccination recommendations for cancer patients. This demonstrates that it is a globally trusted authority during times of crisis. Health.
Improving the patient's quality of life
-
Treatment of oral mucositis: He published a 5-year review on this troublesome side effect for head and neck cancer patients, reflecting his concern not only for killing the tumor, but also for patient comfort during treatment..
-
Pain relief: He has research on the role of radiation in relieving malignant psoas syndrome, which is part of his expertise in palliative care..
Treatment of benign lesions
Publishing an important study on “Radiation therapy for benign brain lesions”. This demonstrates that radiation therapy is not only for cancer; Dr. Haitham also treats non-cancerous conditions in the brain with precision. and effectiveness.
5. Why choose Dr. Haitham Al-Sarairah?
Based on the detailed CV, here are the reasons why Dr. Haitham is the ideal choice for patients:
-
Multidisciplinary Approach: He believes in working within a Tumor Board team to ensure the patient receives the best collective decision..
-
Experience in complex cases: His specialization in thoracic tumors and his experience in brain surgery (SRS) make him qualified for cases where others hesitate.
-
Effective communication: His fluency in Arabic, English, and Greek breaks down language barriers, especially for foreign patients or in medical tourism..
-
The humanitarian aspect: His practice focuses on palliative care and supporting the patient and their family, which is clearly reflected in his research..
6. Frequently Asked Questions (FAQ)
Q: What conditions does Dr. Haitham Al-Sarairah treat? A: Dr. Haitham treats all solid tumors and blood tumors that require radiation.. His subspecialties include: lung cancer, brain tumors, breast cancer, head and neck tumors, and prostate, using the latest IMRT and VMAT technologies.
Q: Does Dr. Haitham treat advanced cases (palliative care)? A: Yes, he has extensive experience in palliative radiotherapy to control symptoms, relieve pain, and improve the quality of life for patients in advanced stages..
Q: What international memberships does he hold? A: He is an active member of the Jordanian Oncology Society and the Hellenic Society of Radiation Oncology, which keeps him up-to-date with the latest European protocols..
Conclusion: A call for hope and healing
Choosing an oncologist is a life-changing decision. Dr. Haitham Al-Sarairah offers his patients expertise honed at prestigious European universities and Jordanian military hospitals. He embodies a blend of rigorous science, continuous research, and genuine compassionate care.
Whether you are looking for a second medical opinion, or a comprehensive treatment plan using the latest radiology techniques, Dr. Haitham is ready to provide advice and treatment.
biography
Dr. Haytham H. Saraireh Radiation Oncology Consultant | Mobile: +962772571298 | E-mail: [email protected] Professional Summary Dr. Haytham Saraireh is a highly experienced Radiation Oncology Consultant with extensive experience in cancer treatment, patient care, and clinical research. With over two decades of medical experience, he has held key leadership roles, including Head of the Radiation Oncology Department at the Royal Medical Services. He holds dual board certifications in Radiation Oncology from both Jordan and Greece and earned a postgraduate studies degree in Thoracic Oncology from the Kapodistrian University of Athens, Greece. His clinical practice encompasses radiation therapy for various cancers, comprehensive patient support, and oncology research, with a strong commitment to improving treatment outcomes. Beyond clinical practice, Dr. Saraireh actively mentors residents in radiation oncology training programs, guiding future specialists in both research and patient care. He is a published author with multiple peer-reviewed articles indexed in PubMed, covering topics such as radiation-induced side effects, the impact of COVID-19 on cancer care, and innovative treatment approaches. Dr. Saraireh maintains strong professional relationships with Radiation Oncology Consultants across Europe, supporting future collaboration in research and participation in international conferences and scientific initiatives. Fluent in Arabic, English, and Greek, Dr. Saraireh collaborates with international oncology societies and contributes to global cancer care guidelines. His dedication to oncology, medical education, and humanitarian values reflects his ongoing leadership in the field. Clinic Oncologic imaging interpretation (CT, MRI, PET-CT) • Clinical trials and research in radiation oncology • Quality assurance and radiation safety protocols • Radiobiology principles and treatment response evaluation Personal Information Marital Status: Married Nationality: Jordanian Date of Birth: 01/22/1978 Place of Birth: Zarqa, Jordan Education Postgraduate Studies in Thoracic Oncology National and Kapodistrian University of Athens – Athens, Greece Awarded: 2016 | Final Grade: Very Good 1997 – 2003: Bachelor Degree of Medicine, Aristotelio University of Thessaloniki, Greece 1996 – 1997: Certificate of Education (TAWJIHI), King Hussein College Work Experience • February 1st, 2025: retired from the Royal Medical Services and have been working in the private sector • Jan 2019 – Oct 2023: Head of Radiation Oncology Department in Royal Medical Services • Apr2021 – Feb 2025: Senior Radiation Oncology Specialist at Royal Medical Services • Feb 2014 – Apr 2021: Radiation Oncology Specialist at Royal Medical Services • Sep 2009 – Sep 2013: Resident at Greek Ministry of Health and Social Solidarity • Apr 2008 – Sep 2009: Clinical Observer - Radiation Oncology, METAXA Cancer Hospital Athens Greece • Jul 2007 – Mar 2008: Radiation Oncology Resident at King Hussein Cancer Center Amman – Jordan • 2006 – 2007: General Physician at Royal Medical Services • 2004 – 2006: Emergency Department, Queen Alia Hospital (General Physician) • 2003 – 2004: Internship at Queen Alia Hospital Licenses and Certifications Jordanian Board of Radiation Oncology (2017) Greek Board of Radiation Oncology (2014) Postgraduate Diploma in Thoracic Oncology (2016), Grade: Very Good Professional Memberships Jordan Oncology Society Greek Radiation Oncology Society Languages Arabic (Native) English (Fluent) Greek (Fluent) Publications: 1. Patient and family support in the era of fake e-medicine: food for thought from an international consensus panel. Mauri D, Kamposioras K, Tzachanis D, Tolia M, Valachis A, Dambrosio M, Alongi F, De Mello RA, Lövey J, Anthony A, Christopoulos C, Saraireh HH, Kountourakis P, Kampletsas E, Tsali L, Tsakiridis T, Kosovitsas I, Soukovelos A, Lymperatou D, Polyzos N, Zarkavelis G. ESMO Open. 2020 Apr; 5(2):e000696. doi: 10.1136/esmoopen-2020-000696. PMID: 32340999 Free PMC article. No abstract available. 2. Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients: Five-Year Literature Review. Gkantaifi A, Vardas E, Alongi F, Tsoukalas N, Saraireh HH, Charalampakis N, Lövey J, Hajiioannou J, Kyrodimos E, Tsanadis K, Mauri D, Christopoulos C, Iliadis G, Tolia M. Rev Recent Clin Trials. 2021; 16(2):151-165. doi: 10.2174/1574887115666200731182708. PMID: 32735527 3. Benign Intracranial Lesions – Radiotherapy: An Overview of Treatment Options, Indications, and Therapeutic Results. Tzikoulis V, Gkantaifi A, Alongi F, Tsoukalas N, Saraireh HH, Charalampakis N, Tzikoulis G, Andreou E, Tsapakidis K, Kardamakis D, Tsanadis K, Kyrgias G, Tolia M. Rev Recent Clin Trials. 2020; 15(2):93-121. doi: 10.2174/1574887114666191111100635. PMID: 31713498 4. Synthesis of Recommendations from 25 Countries and 31 Oncology Societies: How to Navigate Through the COVID-19 Labyrinth. Kamposioras K, Mauri D, Papadimitriou K, Anthony A, Hindi N, Petricevic B, Dambrosio M, Valachis A, Kountourakis P, Kopecky J, Kuhar CG, Popovic L, Chilingirova NP, Zarkavelis G, De Mello RA, Plavetić ND, Christopoulos C, Mostert B, Goffin JR, Tzachanis D, Saraireh HH, Ma F, Pavese I, Tolia M. Front Oncol. 2020 Nov 19; 10:575148. doi: 10.3389/fonc.2020.575148. PMID: 33330049 Free PMC article. Review. 5. COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages – Breaking Barriers to Cancer Patient Information. Mauri D, Kamposioras K, Tsali L, Dambrosio M, De Bari B, Hindi N, Salembier C, Nixon J, Dimitrios T, Alongi F, Hameed H, Valachis A, Papadimitriou K, Corradini S, Popovic L, Kopecky J, Rodriguez A, Antunac K, Yi J, Lövey J, Strojan P, Saraireh H, Røtterud R, Chojnacka M, Olalla SC, Chilingirova N, De Mello RA, Amaral GA, Arbabi F, Vidra R, Rapushi E, Takeuchi D, Christopoulos C, Ivanova I, Djan I, Petricevic B, Cellini F, Mihaylova I, Plavetić ND, Kuhar CG, Takeuchi E, Kountourakis P, Ntellas P, Gazouli I, Gkoura S, Yuce S, Er Ö, Yasmina C, Kumaran G, Spahiu O, Yusuf A, Gono P, Apostolidis K, Tolia M. Rev Recent Clin Trials. 2022; 17(1):11-14. doi: 10.2174/1574887116666211028145848. PMID: 34967300 Free PMC article. 6. Summary of International Recommendations in 23 Languages for Patients with Cancer During the COVID-19 Pandemic. Mauri D, Kamposioras K, Tolia M, Alongi F, Tzachanis D; International Oncology Panel and European Cancer Patient Coalition collaborators. Lancet Oncol. 2020 Jun; 21(6):759-760. doi: 10.1016/S1470-2045(20)30278-3. PMID: 32410877 Free PMC article. No abstract available. 7. Impact of Radiation Therapy on Pain Relief of Cancer Patients Affected by Malignant Psoas Syndrome: 26 Years of Experience. Gerontopoulos A, Mosa E, Alongi F, Kokakis I, Saraireh HH, Tsoukalas N, Charalampakis N, Tsanadis K, Tsapakidis K, Eleni M, Christopoulos C, Tolia M. Indian J Palliat Care. 2020 Jul–Sep; 26(3):348-351. doi: 10.4103/IJPC.IJPC_205_19. PMID: 33311878 Free PMC article. 8. Neurosurgical Perspective of Spontaneous Subarachnoid Hemorrhage Diagnosis: DSA – The Privileged Cardinal Tool. Journal of Royal Medical Service
education
- Bachelor of Medicine, Aristotle University of Thessaloniki – Greece
- Postgraduate studies in breast cancer, National and Kapodistrian University of Athens, Greece
Awards and Recognitions
- Jordanian Board Certification - Therapeutic Radiology (JBC)
- European Board Certification - Radiotherapy (EBC)
Geographic location
Reviews
Write a ReviewThere are no reviews yet.